Waters Corporation announced plans to significantly expand its precision chemistry operation.
Waters Co. will expand precision chemistry operations in Taunton, Massachusetts, US. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as well as on-going innovation in chemistry technology.
The Taunton site is responsible for the bulk synthesis of chromatographic media which is critical to sample analysis for the pharmaceutical, biopharmaceutical, materials, food, clinical and biomedical research applications.
The Taunton project is a noteworthy example of Waters’ capital allocation strategy, which prioritizes investing for long-term growth and innovation.
The company plans to employ LEED (Leadership in Energy and Environmental Design) certification standards. Also, to employ state-of-the-art manufacturing and process technology to construct a new centre-of-excellence. This meets output, cost, quality and sustainability objectives. Specific plans remain subject to refinement, however, the company expects the new plant will be operational by 2022. Until then, the existing Taunton facility will fully meet operational and growth needs.